We use both our own and third-party cookies for statistical purposes and to improve our services. If you continue to browse, we consider that you accept the use of these.

CAP RNA-Seq

Clinical Assays for Treatment Decisions

Our CAP/CLIA accredited laboratory is one of the only clinical laboratories specializing in RNA-based assays.

Leverage the dynamic nature of RNA,  combined with our expertise in clinical samples.

Cofactor offers access to two clinically-validated assays to improve your clinical decision making abilities.

cap_cert_large_print_color

Our ImmunoPrism™ assay quantitatively measures 8 key immune cells in solid tumor samples from as little as two FFPE sections.

RNA-seqDx surveys the entire transcriptome to provide a broad look at a patient’s disease state.

Contact us to discuss how we can provide you with the insights you need.

CAP/CLIA-Grade RNA Sequencing Products

Product Name Catalog Number Description Price per Sample
ImmunoPrism™ Clinical Assay CFGDx-301 Clinically-validated immune characterization for solid tumors Contact Us
RNA-seqDx CFGDx-101CFGDx-102 Fresh-Frozen CAP/CLIA RNA sequencing, 30 million single-end readsFresh-Frozen CAP/CLIA RNA sequencing, 60 million single-end reads $1000$1500

RNA-seqDx includes delivery of FASTQ files only and does not include comparative expression or other advanced analysis.

Learn more about our offerings.

Start typing and press Enter to search